Stocks to Sell

10 Biotechnology Stocks to Sell Now

The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

4 Insurance Stocks to Sell Now

This week, the overall grades of four insurance stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

6 Semiconductor Stocks to Sell Now

This week, the ratings of six semiconductor stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

4 Service Stocks to Sell Now

The overall ratings of four service stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

3 Medical Technology Stocks to Sell Now

For the current week, the overall ratings of three medical technology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

Intel Q1 Earnings: Don’t Expect Much More From INTC Stock

Intel earnings for the first quarter just met Wall Street expectations, and INTC was reacting positively on the news. Read Article

Dump Zillow (Z) Stock Before Bad Turns to Worse

The Zillow (Z) stock price is facing pressure Tuesday after CEO Spencer Rascoff slashed revenue and EBITDA guidance. But the bad news doesn't end there. Read Article

PCLN Stock: Priceline Could Travel Downward

Priceline is the largest of the online travel agents, but its size may not be able to shield it from a growing number of competitors and a weak euro. Read Article

What’s the Story With the Sears Holdings-Simon Properties Deal?

Eddie Lampert is selling off Sears Holdings for spare parts. That doesn't make it a good deal for shareholders. Read Article

7 Biggest, Ugliest Oil Stocks to Sell Now

Crude oil prices stink, crude oil stock performance stinks ... so stop sitting on Big Oil stocks like Exxon Mobil and Chevron and sell already! Read Article

5 Worst Sectors to Avoid This Week

This week, the energy services, marine, construction and engineering, electrical equipment and distributors sectors look weak according to Portfolio Grader. Read Article

5 Stocks With Crummy Earnings Growth — MMLP TCI CGG BGC SHOS

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. Read Article

5 Stocks With Crummy Cash Flow — HXM TWGP HELI STP ATPG

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader. Read Article

YHOO CEO Marissa Mayer Stumbles Over Tumblr

YHOO’s Marissa Mayer reportedly backpedals on promised 'autonomy' for Tumblr as Yahoo's core business continues to shrink. Read Article

12 Metals and Mining Stocks to Sell Now

For the current week, the overall ratings of 12 metals and mining stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

3 Tech Services Stocks to Sell Now

The overall ratings of three tech services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

7 Capital Markets Stocks to Sell Now

The ratings of seven capital markets stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

3 Medical Devices Stocks to Sell Now

This week, the ratings of three medical devices stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Read Article

5 Stocks With Ugly Sales Growth — RNA EXAS GNCA NBIX TENX

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader. Read Article

HomeAway (AWAY) Stock: Offensively Overvalued

HomeAway (AWAY) stock should be kept away from your portfolio at these absurd valuations. The growth prospects simply aren't worth it. Read Article